Literature DB >> 17255510

A plasminogen-activating protease specifically controls the development of primary pneumonic plague.

Wyndham W Lathem1, Paul A Price, Virginia L Miller, William E Goldman.   

Abstract

Primary pneumonic plague is transmitted easily, progresses rapidly, and causes high mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely unknown. We show that the plasminogen activator Pla is essential for Y. pestis to cause primary pneumonic plague but is less important for dissemination during pneumonic plague than during bubonic plague. Experiments manipulating its temporal expression showed that Pla allows Y. pestis to replicate rapidly in the airways, causing a lethal fulminant pneumonia; if unexpressed, inflammation is aborted, and lung repair is activated. Inhibition of Pla expression prolonged the survival of animals with the disease, offering a therapeutic option to extend the period during which antibiotics are effective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255510     DOI: 10.1126/science.1137195

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  153 in total

1.  Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation.

Authors:  Paul A Price; Jianping Jin; William E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-01       Impact factor: 11.205

2.  Structural basis for activation of an integral membrane protease by lipopolysaccharide.

Authors:  Elif Eren; Bert van den Berg
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

Authors:  Christina J van Lier; Jian Sha; Michelle L Kirtley; Anthony Cao; Bethany L Tiner; Tatiana E Erova; Yingzi Cong; Elena V Kozlova; Vsevolod L Popov; Wallace B Baze; Ashok K Chopra
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague.

Authors:  Stephen T Smiley; Frank M Szaba; Lawrence W Kummer; Debra K Duso; Jr-Shiuan Lin
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

5.  Substrate specificity and screening of the integral membrane protease Pla.

Authors:  Anton Agarkov; Sadhana Chauhan; Pedro J Lory; Scott R Gilbertson; Vladimir L Motin
Journal:  Bioorg Med Chem Lett       Date:  2007-10-12       Impact factor: 2.823

6.  Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.

Authors:  V A Feodorova; L N Pan'kina; E P Savostina; O S Kuznetsov; N P Konnov; L V Sayapina; S V Dentovskaya; R Z Shaikhutdinova; S A Ageev; B Lindner; A N Kondakova; O V Bystrova; N A Kocharova; S N Senchenkova; O Holst; G B Pier; Y A Knirel; A P Anisimov; V L Motin
Journal:  Vaccine       Date:  2009-02-13       Impact factor: 3.641

Review 7.  Molecular Darwinian evolution of virulence in Yersinia pestis.

Authors:  Dongsheng Zhou; Ruifu Yang
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

8.  Depletion of Glucose Activates Catabolite Repression during Pneumonic Plague.

Authors:  Jeremy T Ritzert; Wyndham W Lathem
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

9.  Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Authors:  Wei Sun; Kenneth L Roland; Xiaoying Kuang; Christine G Branger; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  The NLRP12 inflammasome recognizes Yersinia pestis.

Authors:  Gregory I Vladimer; Dan Weng; Sara W Montminy Paquette; Sivapriya Kailasan Vanaja; Vijay A K Rathinam; Marie Hjelmseth Aune; Joseph E Conlon; Joseph J Burbage; Megan K Proulx; Qin Liu; George Reed; Joan C Mecsas; Yoichiro Iwakura; John Bertin; Jon D Goguen; Katherine A Fitzgerald; Egil Lien
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.